Loading...
Market
What will be the percentage reduction in Parkinson's symptoms in follow-up trials of the new brain implant by June 30, 2025?
2
Resolution / Starting Odds
Less than 40% • 25%
40% to 50% • 25%
50% to 60% • 25%
More than 60% • 25%
Clinical trial results and publications
Story
New Brain Implant Reduces Parkinson's Symptoms by 50% in Early Trials
Aug 19, 2024, 07:14 PM
Recent studies have shown promising results for a new brain implant technology aimed at alleviating symptoms of Parkinson's disease. This innovative approach involves an intelligent pacemaker that offers deep brain stimulation, providing personalized neuromodulation tailored to individual needs. The device, guided by artificial intelligence, has been shown to reduce Parkinson's symptoms by 50 percent in early trials. Experts suggest that the implant could offer around-the-clock care, adapting to the brain's activity to deliver more effective and long-term relief. This technology represents a significant advancement over current techniques, potentially improving movement and sleep for those affected by Parkinson's.
View original story
Similar markets
Significant improvement • 25%
Moderate improvement • 25%
No significant improvement • 25%
Worsening of symptoms • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than 50% • 25%
50% to 70% • 25%
71% to 90% • 25%
More than 90% • 25%
Less than 50% • 25%
50% to 74% • 25%
75% to 80% • 25%
More than 80% • 25%
Less than 40% • 25%
40% to 60% • 25%
61% to 80% • 25%
More than 80% • 25%
1-5 patients • 25%
6-10 patients • 25%
11-20 patients • 25%
More than 20 patients • 25%
90-94% • 25%
95-98% • 25%
99-99.9% • 25%
100% • 25%
Less than 50% • 33%
50% to 75% • 33%
More than 75% • 33%
0 • 25%
1-5 • 25%
6-10 • 25%
More than 10 • 25%